Join the A&A Webinar on Perioperative Medicine
Register for the Anesthesia & Analgesia Webinar on Perioperative Medicine on June 5! Perioperative Medicine High Impact Bundle Webinar Monday, June 5, 2023 at 3:00…
Related Articles
SAVE THE DATE!
Join Drs. Fudim and Feldman as they discuss Remote Patient Care: A New Era in Cardiovascular Disease Management
404: Page Not Found | Mailchimp
It looks like you’re trying to reach a page that was built by Mailchimp but is no longer active. Want to know more about us?…
Jam Session Registration
We are thrilled to share our new season of the Johns Hopkins Center for Health Equity (CHE) Jam Sessions! CHE invites speakers from a variety of research…
New Articles in Epilepsia – December 28, 2024
Marysol Segovia-Oropeza, Erik Hans Ulrich Rauf, Ev-Christin Heide, Niels K. Focke James Mills, Alessia Romagnolo, Giulia Battaglia, Sara Eyal, Medine I. Gulcebi, Bernadette Macrohon, Sanjay…
Immunology Wrapped 2024
The American Association of Immunologists (AAI) is pleased to present this year in immunology. Scroll to explore top research articles, webinars, scientific sessions, news stories,…
Epilepsia Open – Recently published articles (December 22, 2024)
Raffaele Falsaperla, Vincenzo Sortino, Gerhard Josef Kluger, Thomas Herberhold, Andrea Rüegger, Pasquale Striano, Martino Ruggieri, Joerg Klepper, Georgia Ramantani Carol M. Stephens, Jacopo Proietti, Sean…
New Articles in Epilepsia – December 21, 2024
Nabil Awan, Raj G. Kumar, Shannon B. Juengst, Dominic DiSanto, Cynthia Harrison-Felix, Kristen Dams-O’Connor, Mary Jo Pugh, Ross D. Zafonte, William C. Walker, Jerzy P.…
PROFID – Newsletter 8
Welcome to the eighth PROFID newsletter! The ambition of PROFID is to introduce a disruptive change in the prevention of sudden cardiac death in post-myocardial…
Immunology Wrapped 2024
The American Association of Immunologists (AAI) is pleased to present this year in immunology. Scroll to explore top research articles, webinars, scientific sessions, news stories,…
Lexaria’s Registered GLP-1 Study #4 Begins Dosing
Lexaria’s Registered GLP-1 Study #4 Begins Dosing Registered Phase-1b 12-week study will investigate safety, diabetes control, and weight loss Kelowna, British Columbia – December 19,…
